Trial · NCT03181503
Results by group242
Each measurement the trial posted, group by group, in the words and numbers it posted.
141 to 160 of 242
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Placebo | Excoriation/Crusts: Week 4: Stage 1 | 6 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Nemolizumab 0.5 mg/kg | Excoriation/Crusts: Week 4: Stage 1 | 10 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Placebo | Excoriation/Crusts: Week 4: Stage 2 | 7 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Nemolizumab 0.5 mg/kg | Excoriation/Crusts: Week 4: Stage 2 | 9 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Placebo | Excoriation/Crusts: Week 4: Stage 3 | 10 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Nemolizumab 0.5 mg/kg | Excoriation/Crusts: Week 4: Stage 3 | 9 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Placebo | Excoriation/Crusts: Week 4: Stage 4 | 9 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Nemolizumab 0.5 mg/kg | Excoriation/Crusts: Week 4: Stage 4 | 3 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Placebo | Excoriation/Crusts: Week 8: Stage 0 | 2 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Nemolizumab 0.5 mg/kg | Excoriation/Crusts: Week 8: Stage 0 | 4 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Placebo | Excoriation/Crusts: Week 8: Stage 1 | 5 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Nemolizumab 0.5 mg/kg | Excoriation/Crusts: Week 8: Stage 1 | 13 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Placebo | Excoriation/Crusts: Week 8: Stage 2 | 7 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Nemolizumab 0.5 mg/kg | Excoriation/Crusts: Week 8: Stage 2 | 6 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Placebo | Excoriation/Crusts: Week 8: Stage 3 | 11 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Nemolizumab 0.5 mg/kg | Excoriation/Crusts: Week 8: Stage 3 | 9 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Placebo | Excoriation/Crusts: Week 8: Stage 4 | 7 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Nemolizumab 0.5 mg/kg | Excoriation/Crusts: Week 8: Stage 4 | 0 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Placebo | Excoriation/CrustsWeek 12: Stage 0 | 1 | Participants | |
| Prurigo Activity Score (PAS) Item 6: Number of Participants With Defined Stages of Excoriation/Crusts and Healed Lesions at Each Visit | Nemolizumab 0.5 mg/kg | Excoriation/CrustsWeek 12: Stage 0 | 3 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03181503/results?page=8